Skip to main content

Table 2 Details of the intravenous therapy for the neonate participants

From: Clinical practice guideline on the prevention and management of neonatal extravasation injury: a before-and-after study design

Variables Control Group (n = 104)
F (%)
Intervention Group (n = 109)
F (%)
p-value for difference
Peripheral IV device for continuous infusion. 53 (50.96) 52 (47.71) 0.64
Peripheral IV device with vesicant administration. 11 (10.58) 17 (15.60) 0.28
Number of peripheral IV catheter in-situ. Mean (SD)
2.88 (2.85)
Mean (SD)
2.86 (2.96)
0.96#
Peripheral IV catheter days. Mean (SD)
8.22 (8.76)
Mean (SD)
9.48 (8.79)
0.30#
Number of patients with CVC. 26 (25%) 31 (28.44%) 0.40
Number of CVC in-situ. Mean (SD)
1.58 (0.50)
Mean (SD)
1.45 (0.51)
0.36#
CVC days. Mean (SD)
15.58 (8.41)
Mean (SD)
14.23 (6.97)
0.51#
  1. Abbreviations:CVC Central venous catheter, F Frequency, IV Intravenous,SD Standard deviation ‡ By χ2test
  2. # p-value for mean difference by independent sample t-test